Case number 2018-1061
Reckitt Benckiser Pharm. v. Par Pharmaceutical, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 8, 2018 | 37 | ORDER filed. The motion to dismiss appeals 16-2277, 16-2278, 16-2397, 16-2398, 18-1061, and 18-1119 pursuant to FRAP 42(b) [524838-2] is granted and the mandate is issued. The revised official caption for 17-2587, 18-1010, -1058, -1062, -1114, -1115, -1176, -1177 is reflected in the order. - FOR CALENDAR. Service as of this date by the Clerk of Court. [528099] [16-2277, 16-2278, 16-2397, 16-2398, 18-1061, 18-1119, 17-2587, 18-1010, 18-1058, 18-1062, 18-1114, 18-1115, 18-1176, 18-1177] [MJL] [Entered: 06/08/2018 03:35 PM] (4) |
| Nov 1, 2017 | 36 | Note to file: The following cases are consolidated:16-2277 (Lead) with 16-2278, 16-2397, 16-2398, 17-2587, 18-1010, 18-1058, 18-1061, 18-1062, 18-1114, 18-1115, 18-1119 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [472364] [JB] [Entered: 11/01/2017 04:22 PM] (0) |
| Nov 1, 2017 | 35 | ORDER consolidating appeals (16-2277 (Lead) with 16-2278, 16-2397, 16-2398, 17-2587, 18-1010, 18-1058, 18-1061, 18-1062, 18-1114, 18-1115, 18-1119 (Members)). These appeals are consolidated. The revised official caption is reflected above. The appeallants' opening briefs are due no late than December 15, 2017. Service as of this date by Clerk of Court. [472356] [JB] [Entered: 11/01/2017 04:07 PM] (2) |
| Oct 31, 2017 | 34 | Amended Certificate of Interest for the Cross-Appellant IntelGenX Technologies Corp.. Service: 10/31/2017 by email. [471925] [Daniel Brown] [Entered: 10/31/2017 01:26 PM] (3) |
| Oct 31, 2017 | 33 | Amended Certificate of Interest for the Cross-Appellant Par Pharmaceutical, Inc.. Service: 10/31/2017 by email. [471922] [Daniel Brown] [Entered: 10/31/2017 01:23 PM] (3) |
| Oct 31, 2017 | 32 | NOTICE OF DEFICIENCY: The certificate of interest [15] filed by Cross-Appellant IntelGenX Technologies Corp., certificate of interest [13] filed by Cross-Appellant Par Pharmaceutical, Inc. in 18-1061 is incomplete and therefore cannot be accepted for filing at this time. CLERK'S NOTE: The Certificate of Interest form has been updated, as of 10/02/2017, to include Question #5 regarding related cases. Please re-file using the updated Certificate of Interest form available on the court's website.] You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected documents may be accepted for filing if received before midnight (EST) on the date of this notice. [471889] [JB] [Entered: 10/31/2017 12:09 PM] (0) |
| Oct 31, 2017 | 31 | Official caption revised to add Cross-Appeal 18-1119. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [471752] [JB] [Entered: 10/31/2017 09:27 AM] (0) |
| Oct 31, 2017 | 30 | Note to file: The following cases are associated:18-1061 (Lead) with 18-1119 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [471750] [JB] [Entered: 10/31/2017 09:26 AM] (0) |
| Oct 30, 2017 | 9 | Entry of appearance for Cassandra A. Adams as of counsel for Appellant MonoSol Rx, LLC. Service: 10/30/2017 by email. [471602] [Cassandra Adams] [Entered: 10/30/2017 06:04 PM] (2) |
| Oct 30, 2017 | 10 | Certificate of Interest for the Appellant MonoSol Rx, LLC. Service: 10/30/2017 by email. [471603] [Cassandra Adams] [Entered: 10/30/2017 06:05 PM] (3) |
| Oct 30, 2017 | 11 | Docketing Statement for the Appellant MonoSol Rx, LLC. Service: 10/30/2017 by email. [471604] [Cassandra Adams] [Entered: 10/30/2017 06:06 PM] (5) |
| Oct 30, 2017 | 12 | Entry of appearance for Daniel G. Brown as principal counsel for Appellees IntelGenX Technologies Corp. and Par Pharmaceutical, Inc.. Service: 10/30/2017 by email. [471639] [Daniel Brown] [Entered: 10/30/2017 07:20 PM] (3) |
| Oct 30, 2017 | 13 | Certificate of Interest for the Appellee Par Pharmaceutical, Inc.. Service: 10/30/2017 by email. [471641] [Daniel Brown] [Entered: 10/30/2017 07:23 PM] (0) |
| Oct 30, 2017 | 14 | Entry of appearance for James M. Bollinger as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471642] [James Bollinger] [Entered: 10/30/2017 07:28 PM] (1) |
| Oct 30, 2017 | 15 | Certificate of Interest for the Appellee IntelGenX Technologies Corp.. Service: 10/30/2017 by email. [471643] [Daniel Brown] [Entered: 10/30/2017 07:28 PM] (0) |
| Oct 30, 2017 | 16 | Docketing Statement for the Appellees IntelGenX Technologies Corp. and Par Pharmaceutical, Inc.. Service: 10/30/2017 by email. [471644] [Daniel Brown] [Entered: 10/30/2017 07:29 PM] (5) |
| Oct 30, 2017 | 17 | Entry of appearance for Charanjit Brahma as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471645] [Charanjit Brahma] [Entered: 10/30/2017 07:31 PM] (2) |
| Oct 30, 2017 | 18 | Entry of appearance for Timothy P. Heaton as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471647] [Timothy Heaton] [Entered: 10/30/2017 07:33 PM] (2) |
| Oct 30, 2017 | 19 | Entry of appearance for Gabriel K. Bell as of counsel for Appellees IntelGenX Technologies Corp. and Par Pharmaceutical, Inc.. Service: 10/30/2017 by email. [471648] [Gabriel Bell] [Entered: 10/30/2017 07:33 PM] (3) |
| Oct 30, 2017 | 20 | Entry of appearance for Magnus Essunger as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471650] [Magnus Essunger] [Entered: 10/30/2017 07:36 PM] (2) |
| Oct 30, 2017 | 21 | Entry of appearance for Robert J. Gajarsa as of counsel for Appellees IntelGenX Technologies Corp. and Par Pharmaceutical, Inc.. Service: 10/30/2017 by email. [471652] [Robert Gajarsa] [Entered: 10/30/2017 07:38 PM] (3) |
| Oct 30, 2017 | 22 | Entry of appearance for Dustin B. Weeks as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email, clerk. [471654] [Dustin Weeks] [Entered: 10/30/2017 07:39 PM] (2) |
| Oct 30, 2017 | 23 | Entry of appearance for Terry Kearney as of counsel for Appellees IntelGenX Technologies Corp. and Par Pharmaceutical, Inc.. Service: 10/30/2017 by email. [471657] [Terry Kearney] [Entered: 10/30/2017 07:42 PM] (3) |
| Oct 30, 2017 | 24 | Entry of appearance for Gerald E. Porter as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email, clerk. [471658] [Gerald Porter] [Entered: 10/30/2017 07:44 PM] (2) |
| Oct 30, 2017 | 25 | Certificate of Interest for the Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email, clerk. [471659] [Timothy Heaton] [Entered: 10/30/2017 07:46 PM] (5) |
| Oct 30, 2017 | 26 | Entry of appearance for Michelle P. Woodhouse as of counsel for Appellees IntelGenX Technologies Corp. and Par Pharmaceutical, Inc.. Service: 10/30/2017 by email. [471660] [Michelle Woodhouse] [Entered: 10/30/2017 07:46 PM] (3) |
| Oct 30, 2017 | 27 | Docketing Statement for the Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email, clerk. [471662] [Timothy Heaton] [Entered: 10/30/2017 07:47 PM] (6) |
| Oct 30, 2017 | 28 | Entry of appearance for Gabrielle LaHatte as of counsel for Appellees IntelGenX Technologies Corp. and Par Pharmaceutical, Inc.. Service: 10/30/2017 by email. [471665] [Gabrielle LaHatte] [Entered: 10/30/2017 07:50 PM] (3) |
| Oct 30, 2017 | 29 | Entry of appearance for Daniel A. Ladow as principal counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email, clerk. [471671] [Daniel Ladow] [Entered: 10/30/2017 08:00 PM] (2) |
| Oct 30, 2017 | 8 | Entry of appearance for James Francis Hibey as principal counsel for Appellant MonoSol Rx, LLC. Service: 10/30/2017 by email. [471601] [James Hibey] [Entered: 10/30/2017 06:02 PM] (2) |
| Oct 30, 2017 | 7 | Entry of appearance for Matthew Kudzin as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471566] [Erica Andersen] [Entered: 10/30/2017 05:19 PM] (2) |
| Oct 30, 2017 | 6 | Entry of appearance for Jeffrey H. Lerner as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471565] [Erica Andersen] [Entered: 10/30/2017 05:18 PM] (2) |
| Oct 30, 2017 | 5 | Entry of appearance for Jeffrey B. Elikan as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471564] [Erica Andersen] [Entered: 10/30/2017 05:17 PM] (2) |
| Oct 30, 2017 | 4 | Entry of appearance for R. Jason Fowler as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471563] [Erica Andersen] [Entered: 10/30/2017 05:16 PM] (2) |
| Oct 30, 2017 | 3 | Entry of appearance for Beth S. Brinkmann as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471562] [Erica Andersen] [Entered: 10/30/2017 05:15 PM] (2) |
| Oct 30, 2017 | 2 | Entry of appearance for Erica N. Andersen as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471560] [Erica Andersen] [Entered: 10/30/2017 05:14 PM] (2) |
| Oct 16, 2017 | 1 | Appeal docketed. Received: 10/16/2017. [468112]Entry of Appearance due 10/30/2017. Certificate of Interest is due on 10/30/2017. Docketing Statement due 10/30/2017. Appellant/Petitioner's brief is due 12/15/2017. [JB] [Entered: 10/16/2017 02:56 PM] (32) |
